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Abstract
Background: Slow coronary flow (SCF) is slow dye progression in the coronary arteries
during selective angiography, but there is no such study about greater visceral vessels. Studies
have suggested that flow-mediated dilation (FMD) is impaired in SCF. Endothelial function
can be assessed by FMD in the brachial artery as ischemia-induced vasodilation. Since in-
flammation is an underlying pathology in the inflammation of visceral vessels and probably
SCF, we studied the correlation of aortic ectasia and SCF by means of FMD.
Methods: Patients with normal coronary arteries and SCF formed the case group, and patients
with normal coronary arteries and normal coronary flow formed the control group. We meas-
ured the diameter of the patients’ brachial artery at rest, after inflation of a sphygmomanometer
on the forearm [endothelial-dependent vasodilation (EDV)], and after use of sublingual nitrate
(endothelial-independent vasodilation) by sonography. We also measured the diameter of the
aorta using sonography before administration of sublingual nitrate. Endothelial dysfunction
was defined as EDV significantly less than standard EDV.
Results: There were insignificant differences between age, gender, and frequency of cardiac
risk factors within the case and control groups, but diabetes mellitus was significantly differ-
ent between the two groups. The diameter of the aorta was insignificantly different between the
case and control groups. The response of the brachial artery to the cuff test and sublingual
nitrate were insignificantly different between the case and control groups. Endothelial dysfunc-
tion based on cuff test and sublingual nitrate administration was significantly more common
in men than women, as the p values for cuff and sublingual nitrate were 0.033 and 0.051,
respectively.
Conclusions: It seems that there is no correlation between SCFP and aortic ectasia. (Cardiol J
2009; 16, 2: 146–150)
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Introduction
Slow coronary flow phenomenon (SCFP),
which was first described in 1972 as the detection
of slow dye progression in the coronary arteries
during selective coronary angiography [1], is repor-
ted in approximately 1% of patients undergoing
coronary angiography [2]. Its exact pathophysiolo-
gical mechanism is unclear; however, increased
flow resistance due to some small vessel involve-
ment, increased microvascular tone [1, 3–5], plate-
let dysfunction [6], early demonstration of diffuse
atherosclerosis [7], inflammation [8], and an imba-
lance of vasoactive substances [9–11] have been
suggested as underlying mechanisms. Furthermo-
re, several recent studies have observed that coro-
nary flow reserve (which reflects coronary micro-
vascular function) [12], resting microvascular resi-
stance [13], and flow-mediated dilation (a simple and
non-invasive method for determining endothelial
function) were impaired in patients with SCFP [14];
however, all of these studies suffered from the
major limitation of a small sample size.
Endothelial function of coronary arteries can be
assessed by flow-mediated vasodilation (FMD) in
the brachial artery [15]. During the1990s, a noni-
nvasive technique was developed to facilitate the
repetitive measurement of endothelium-dependent
function by measuring brachial artery flow-media-
ted vasodilation [16]. In this method, transient
ischemia in the forearm leads to a local increase in
blood flow, which in turn provokes the endothelium
to release nitric oxide with subsequent vasodilation.
This vasodilation can be imaged and quantified as
an index of vasomotor function [17].
Despite the studied correlation of lesser ves-
sels (especially coronary arteries) with SCFP, the-
re is no study concerning the correlation between
SCFP and the diameter of greater visceral vessels
like the aorta. Considering inflammation as an un-
derlying pathology in both inflammatory conditions
of visceral vessels and probably SCFP, we studied
the correlation of aortic ectasia and SCFP. The pur-
pose of the present study is to evaluate endothelial
function in patients with SCFP by means of FMD
and to compare the diameter of their aorta with
normal coronary persons and SCFP.
Methods
Study population
This case-control study was conducted in the
“Tehran Heart Centre” (Tehran University of Me-
dical Sciences) between January 2006 and Decem-
ber 2006. We obtained the patients’ data from the
angiography databank of the hospital. Patients who
underwent coronary angiography due to anginal
chest pain but whose angiography showed no signi-
ficant coronary stenosis were entered into this stu-
dy. The patients who had undergone thrombolysis
or percutaneous coronary intervention at time of
admission, had received any kind of antihyperten-
sive or vasoactive therapy within 24 hours before
sonography, or had moderate to severe valvular
heart disease or muscle bridge in angiography were
excluded from the study. Inclusion criteria for the
case group were epicardial normal coronary and
SCFP in elective angiography (n = 45). On the other
hand, patients with normal coronary angiography
and normal coronary flow (n = 81) were assigned
to the control group. According to corrected throm-
bolysis in myocardial infarction (TIMI) frame count,
SCFP was defined as more than 2 standard devia-
tions of frame count (TIMI 2) from the normal pu-
blished range for that particular vessel [18]. A sin-
gle experienced cardiologist reviewed all the pa-
tients’ angiography and calculated the frame count.
Normal coronary artery was defined as no stenosis
even at < 50% of the diameter of the coronary arte-
ry. Every subject read and signed an “informed con-
sent” form, approved by the Ethics Committee of
Tehran Heart Centre, before entrance to the study.
Procedure technique
All case and control subjects underwent sono-
graphy by a single experienced sonographer, blind
to the angiographic results, the day after angiogra-
phy. Sonography technique for measurement of
FMD was according to “guidelines for the ultraso-
und assessment of endothelial-dependent flow-
mediated vasodilation of the brachial artery” [17].
The sonographer first measured the diameter of
patient’s brachial artery at rest and recorded it as
a baseline value (GE LOGIQ 5 Expert Doppler so-
nography machine with linear 10 MHz transducer,
United States). Thereafter, he placed the cuff of
a sphygmomanometer on the patient’s forearm and
inflated it for 5 minutes. Within 2 minutes after
deflation of the cuff, he recorded the percentage of
increased diameter of the brachial artery [endothe-
lial-dependent flow-mediated vasodilation (EDFV)].
When the diameter of the brachial artery returned
to baseline, the sonographer applied 2 puffs of sub-
lingual nitrate spray (Nitromint, Egis Pharmaceu-
ticals Ltd., Hungary) and recorded the percentage
of increased diameter of the brachial artery (endo-
thelial-independent flow-mediated vasodilation). If
EDFV in each subject was significantly less than its
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standard reference, it was considered as endothe-
lia dysfunction. In addition, the sonographer measu-
red and recorded maximal transverse diameter of
all the patients’ abdominal aorta (GE LOGIQ 5
Expert Doppler sonography machine with curved
linear 3 MHz probe, United States) before admini-
stration of sublingual nitrate.
We compared the patients’ age, gender, smo-
king habit (according to CDC definition [19], hema-
tological indices (red and white blood cell count,
platelet count, and hemoglobin concentration),
lipid profile — triglyceride, cholesterol, high den-
sity lipoprotein and low density lipoprotein, ac-
cording to the updated Framingham guidance
[20], fasting blood sugar (levels, diabetes melli-
tus (according to American Diabetes Association
Guidelines [21]), hypertension (according to accor-
ding to Joint National Committee sixth report [22]),
serum level of blood urea and creatinine, and
diameter of aorta between the case and control
groups.
The study was approved by the local bioethi-
cal committee and all patients gave their informed
consent.
Statistical analysis
We used the independent two-sample T test to
compare the mean differences of the variables men-
tioned above. We also applied the c2 test to investi-
gate the correlation of SCFP with age, gender,
diabetes mellitus, hypertension, smoking habit, and
coronary diameter. Uni- and multivariate regression
analysis was used to investigate the correlation of
frame count and FMD with endothelial dysfunction
and other variables. All statistical calculations were
done with SPSS v. 13. A P value < 0.05 was consi-
dered significant.
Results
Patients’ characteristics are shown in Table 1.
There were no significant differences between
mean age, gender distribution, and frequency of
cardiac risk factors within the case and control gro-
ups, but, as can be seen, diabetes mellitus (DM) was
significantly different between those two groups.
Table 2 shows the correlation of the diameter
of the aorta with slow coronary flow phenomenon.
As can be seen seen, there is no significant diffe-
rence between case and control groups regarding
the diameter of the aorta.
Table 3 shows the response of brachial artery
to the administration of cuff and sublingual glyceryl
trinitrate (TNG). It is clear that the responses of
brachial arteries to both cuff test and administra-
tion of sublingual TNG were insignificantly diffe-
rent between the case and control groups. After ap-
plication of uni- and multivariate regression to in-
vestigate the correlation of endothelial dysfunction
with frame count, neither frame count nor mean
Table 1. Patient characteristics.
Characteristic Control (n = 81) Case (n = 45) P
Clinical data
Mean age (years) 54.17±8.79 54.20±9.67 0.987
Gender
Male 35 (43.2%) 20 (44.4%)
0.893
Female 46 (56.8%) 25 (55.6%)
Diabetes mellitus 16 (19.8%) 2 (4.4%) 0.019
Hypertension 22 (27.2%) 11 (24.4%) 0.740
Smoking 16 (20.0%) 5 (11.9%) 0.260
Biochemical data (mean)
Triglyceride 167±75.2 203.3±151.9 0.142
Cholesterol 191.5±38.9 193.7±44.8 0.776
LDL cholesterol 111.6±34 109.6±35.5 0.770
HDL cholesterol 45.57±11.3 45.3±11.06 0.906
Platelet 216493±54953 200311±44340 0.093
Hemoglobin 13.95±1.6 14.5±1.4 0.068
Urea 32.1±9.5 33.1±7.9 0.546
Creatinine 1.00±0.26 1.04±0.21 0.329
LDL — low density lipoprotein; HDL — high density lipoprotein
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frame count in any coronary vessel showed any re-
lationship with endothelial dysfunction. After adju-
stment for age, gender, smoking habit, hypertension,
diabetes mellitus, dyslipidemia, and level of serum
creatinine, the p value for this correlation was 0.839.
We found that endothelial dysfunction based on cuff
and TNG administration was significantly more com-
mon in men than in women, as the p values for cuff
and TNG were 0.033 and 0.051, respectively.
Discussion
Slow flow coronary phenomenon is sometimes
considered as a new category of coronary disease
with unknown etiology and indefinite outcome [23].
Several surveys have investigated the relationship
between SCFP and endothelial dysfunction as
a probable etiology. In the present study we tried to
ascertain whether there is a relationship between
the diameter of the aorta and SCFP. Analysis sho-
wed that there were no significant differences be-
tween the patients’ mean age, gender distribution,
and presence of heart disease risk factors in the case
and control groups. A study by Beltrame and colle-
agues also indicated that there was no difference
between these characteristics within the case and
control groups [5]. In addition, Erdogan et al. [12]
reported no significant difference between corona-
ry risk factors in normal coronary and SCFP pa-
tients. Fineschi et al. [13] verified the same result.
Sezgin et al. [14] emphasized the same finding, and
Yigit et al. [24] concluded that the above-mentio-
ned factors had no significant difference within nor-
mal coronary and SCFP patients.
On the other hand, DM was significantly more
common in the control (healthy) group, but since
analysis of the covariance for omission of the con-
founding effect of DM resulted in insignificant
p values, we could conclude that the reverse frequ-
ency of DM in healthy people did not affect the cor-
relation between endothelial dysfunction and slow
coronary flow phenomenon [25].
We found an insignificant difference between
the case and control patients’ aorta diameters. The-
refore, if there is any aneurysm or dilation in the
aorta we can assign it to other underlying reasons.
Conclusions
It seems that there is no correlation between
slow flow phenomenon and diameter of aorta.
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